Why the study?
Parenteral loop diuretic administration is often needed in severe heart disease, prompting an evaluation of clinical outcomes with continuous subcutaneous infusion of furosemide.
Does continuous subcutaneous infusion of furosemide improve symptoms and achieve treatment goals in patients with severe heart failure?
Population
116 patients with NYHA class 3 or 4 heart failure
Comparison
Continuous subcutaneous infusion of furosemide
Design
Retrospective review of service improvement data
Authors
Loading...
May support symptom management for severe HF in community settings; hypothesis-generating and requires RCTs before practice change.
Does continuous subcutaneous infusion of furosemide improve symptoms and achieve treatment goals in patients with severe heart failure?
Continuous subcutaneous infusion of furosemide appears safe and effective for managing severe heart failure in community and hospice settings, achieving treatment goals in over 90% of episodes.
Birch et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: